1 follower
RosVivo Therapeutics targets diseases with breakthrough therapies utilizing microRNA (miRNA) and small interfering-RNA (siRNA) drugs. They're using unique scientific insights to develop a new pipeline of first-in-class drugs and diagnostic tests. Their development programs focus on the leading T2D,... Read more
Junghak Kim